Equities researchers at StockNews.com began coverage on shares of 22nd Century Group (NASDAQ:XXII – Get Free Report) in a report released on Thursday. The brokerage set a “sell” rating on the biotechnology company’s stock.
22nd Century Group Stock Performance
Shares of XXII opened at $4.95 on Thursday. The company’s 50 day simple moving average is $13.03 and its 200-day simple moving average is $52.86. The firm has a market cap of $1.70 million, a PE ratio of -0.22 and a beta of 1.50. 22nd Century Group has a 12-month low of $3.90 and a 12-month high of $581.85. The company has a current ratio of 1.09, a quick ratio of 0.93 and a debt-to-equity ratio of 1.59.
22nd Century Group (NASDAQ:XXII – Get Free Report) last issued its quarterly earnings data on Tuesday, November 12th. The biotechnology company reported ($72.90) earnings per share (EPS) for the quarter. The business had revenue of $5.95 million for the quarter. 22nd Century Group had a negative return on equity of 380.39% and a negative net margin of 144.09%.
Institutional Trading of 22nd Century Group
22nd Century Group Company Profile
22nd Century Group, Inc, a tobacco products company, engages in the sale and distribution of its own proprietary new reduced nicotine tobacco products. The company offers reduced nicotine content tobacco plants and very low nicotine combustible cigarette products. It also provides contract manufacturing services for conventional combustible tobacco products for third-party brands.
See Also
- Five stocks we like better than 22nd Century Group
- Are Penny Stocks a Good Fit for Your Portfolio?
- Opal Fuels CEO on Steering the Future of Renewable Natural Gas
- Investing in the High PE Growth Stocks
- MicroStrategy Joins Nasdaq-100: 2 Crypto Stocks Set to Win
- What is an Earnings Surprise?
- 2 Underrated Quantum Computing Companies Starting to Rally
Receive News & Ratings for 22nd Century Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 22nd Century Group and related companies with MarketBeat.com's FREE daily email newsletter.